Aelis Farma Logo

Aelis Farma

ISIN: FR0014007ZB4 | Ticker: AELIS | LEI: 8945008D5R6WV7EXRN47

About Aelis Farma

Company Description

Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases.

Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments.

These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology.

Year founded





Neurocentre François Magendie 146 Rue Léo Saignat, 33000 Bordeaux – France

Filings & Publications

Shareholder information

Shares outstanding



Feb. 18, 2022

Stock exchange(s)

Euronext Paris

Contact Investor Relations department


Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.